Marketaxess Holdings Inc
MKTX Nasdaq Security Brokers, Dealers & Flotation Companies Financials FY2016βFY2025
What Marketaxess Holdings Inc does
No business description yet.
- Legal name
- MARKETAXESS HOLDINGS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001193125-26-067009
0001278021
Revenue and margins
Marketaxess Holdings Inc had $846M of revenue in fiscal 2025, up 3.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 7.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $374M in fiscal 2025, 44.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Marketaxess Holdings Inc returned $420M to shareholders in fiscal 2025, 112% of free cash flow. The diluted share count fell 1.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Marketaxess Holdings Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $507M | $431M | $451M | $544M | $520M |
| Debt incl. finance leases | β | β | β | $0.1M | $220M |
| Net debt / EBITDA | β | β | β | β1.3x | β0.7x |
| Debt / equity | β | β | β | 0.0x | 0.2x |
| Interest coverage | 400.5x | 467.0x | 158.9x | 212.9x | 229.9x |
| Total assets | $1.5B | $1.6B | $2.0B | $1.8B | $1.9B |
| Total liabilities | $489M | $527M | $722M | $401M | $777M |
| Shareholders' equity | $1.0B | $1.1B | $1.3B | $1.4B | $1.1B |
| Net debt (β = net cash) | β | β | β | β$544M | β$300M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | 4 / 7 |
| Accruals ratio | 6.9% | β3.6% | β8.0% | β7.4% | β9.2% | β1.7% | β2.5% | β4.2% | β5.8% | β7.3% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $370M | $397M | $436M | $511M | $689M | $699M | $718M | $753M | $817M | $846M |
| Operating income | $190M | $200M | $213M | $251M | $375M | $337M | $327M | $315M | $341M | $342M |
| Interest expense | β | β | β | β | $1.1M | $0.8M | $0.7M | $2.0M | $1.6M | $1.5M |
| Pretax income | $192M | $202M | $218M | $257M | $374M | $334M | $338M | $333M | $361M | $367M |
| Income tax | $65.4M | $53.7M | $45.2M | $52.5M | $75.0M | $76.0M | $88.1M | $74.6M | $86.4M | $120M |
| Net income | $126M | $148M | $173M | $205M | $299M | $258M | $250M | $258M | $274M | $247M |
| Diluted EPS | $3.34 | $3.89 | $4.57 | $5.40 | $7.85 | $6.77 | $6.65 | $6.85 | $7.28 | $6.64 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $89.7M | $168M | $224M | $266M | $404M | $282M | $289M | $334M | $385M | $382M |
| Capital expenditure | $6.4M | $12.1M | $35.9M | $12.3M | $15.0M | $17.5M | $13.1M | $9.3M | $9.9M | $8.2M |
| Free cash flow | $83.4M | $156M | $188M | $254M | $389M | $265M | $276M | $324M | $375M | $374M |
| Depreciation and amortization | $17.8M | $19.3M | $23.1M | $26.9M | $36.0M | $53.4M | $61.4M | $70.6M | $73.8M | $76.7M |
| Stock-based compensation | $14.5M | $14.4M | $15.9M | $25.3M | $25.6M | $27.3M | $29.9M | $29.2M | $29.7M | $30.9M |
| Acquisitions | β | β | β | β | β | β | β | $78.5M | $0.0M | $36.5M |
| Share buybacks | $23.9M | $42.5M | $25.2M | $17.3M | $16.1M | $63.2M | $87.5M | $0.0M | $75.5M | $420M |
| Dividends and buybacks | $23.9M | $42.5M | $25.2M | $17.3M | $16.1M | $63.2M | $87.5M | $0.0M | $75.5M | $420M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $168M | $167M | $246M | $270M | $461M | $507M | $431M | $451M | $544M | $520M |
| Total debt | β | β | β | β | β | β | β | β | $0.0M | $220M |
| Finance lease liabilities | β | β | β | β | β | β | β | $0.2M | $0.1M | β |
| Property and equipment, net | $31.1M | $38.5M | $63.0M | $71.8M | $85.2M | $96.1M | $100M | $103M | $107M | $112M |
| Goodwill | β | β | $59.7M | $147M | $147M | $155M | $155M | $237M | $237M | $284M |
| Intangible assets | $3.7M | $3.3M | $3.0M | $61.0M | $95.4M | $116M | $98.1M | $119M | $98.1M | $111M |
| Total assets | $528M | $581M | $696M | $955M | $1.3B | $1.5B | $1.6B | $2.0B | $1.8B | $1.9B |
| Total liabilities | $60.0M | $66.5M | $87.7M | $185M | $376M | $489M | $527M | $722M | $401M | $777M |
| Preferred stock | β | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $468M | $515M | $608M | $770M | $955M | $1.0B | $1.1B | $1.3B | $1.4B | $1.1B |
| Margins | ||||||||||
| Operating margin | 51.4% | 50.2% | 48.8% | 49.1% | 54.4% | 48.2% | 45.5% | 41.9% | 41.7% | 40.4% |
| EBITDA margin | 56.2% | 55.1% | 54.1% | 54.3% | 59.6% | 55.9% | 54.1% | 51.2% | 50.8% | 49.5% |
| Net margin | 34.1% | 37.3% | 39.7% | 40.1% | 43.4% | 36.9% | 34.8% | 34.3% | 33.6% | 29.1% |
| FCF margin | 22.5% | 39.2% | 43.2% | 49.6% | 56.5% | 37.9% | 38.4% | 43.1% | 45.9% | 44.2% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | 30.7% | 27.2% |
| Return on equity | 27.0% | 30.1% | 30.8% | 29.7% | 34.7% | 25.8% | 23.6% | 21.7% | 20.4% | 19.5% |
| Return on assets | 23.9% | 26.7% | 27.1% | 24.8% | 26.2% | 18.0% | 15.9% | 14.2% | 14.4% | 13.2% |
| Return on tangible equity | 27.2% | 29.0% | 31.7% | 36.4% | 42.0% | 33.5% | 30.2% | 27.5% | 26.0% | 32.8% |
| Growth | ||||||||||
| Revenue growth | β | 7.4% | 9.6% | 17.4% | 34.8% | 1.4% | 2.8% | 4.8% | 8.6% | 3.6% |
| Net income growth | β | 17.4% | 16.7% | 18.5% | 46.1% | β13.9% | β3.0% | 3.1% | 6.2% | β10.0% |
| EPS growth | β | 16.5% | 17.5% | 18.2% | 45.4% | β13.8% | β1.8% | 3.0% | 6.3% | β8.8% |
| FCF growth | β | 87.1% | 20.6% | 34.9% | 53.6% | β32.1% | 4.3% | 17.5% | 15.7% | β0.4% |
| Share count change | β | 0.8% | β0.5% | 0.3% | 0.5% | β0.1% | β1.2% | 0.0% | 0.0% | β1.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | β1.3x | β0.7x |
| Debt / equity | β | β | β | β | β | β | β | β | 0.0x | 0.2x |
| Interest coverage | β | β | β | β | 328.1x | 400.5x | 467.0x | 158.9x | 212.9x | 229.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 3.0% | 8.2% | 2.4% | 2.2% | 2.5% | 1.8% | 1.2% | 1.2% | 1.0% |
| Stock comp / revenue | 3.9% | 3.6% | 3.6% | 4.9% | 3.7% | 3.9% | 4.2% | 3.9% | 3.6% | 3.7% |
| Payouts / FCF | 28.7% | 27.2% | 13.4% | 6.8% | 4.1% | 23.9% | 31.7% | 0.0% | 20.1% | 112.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | β | β | β | 4.0 |
| Accruals ratio | 6.9% | β3.6% | β8.0% | β7.4% | β9.2% | β1.7% | β2.5% | β4.2% | β5.8% | β7.3% |
Source: SEC EDGAR XBRL filings (CIK 0001278021). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.